20/20 Biolabs, Inc. (AIDX) Insider Trading Disclosures
20/20 Biolabs, Inc. (AIDX) is a publicly traded company on the Nasdaq, categorized under SIC 8734 (Services-Testing Laboratories). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: AIDX
CIK: 1139685
Exchange: Nasdaq
SIC 8734: Services-Testing Laboratories
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
DBBMCKENNON
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerRuss Boyer
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| PRE 14A | 2026-10-06 | 2026-10-06 | PRELIMINARY PROXY STATEMENT | 0001213900-26-107251 | View SEC Doc Filr Page |
| 8-K | 2026-09-18 | 2026-09-16 | CURRENT REPORT | 0001213900-26-101405 | View SEC Doc Filr Page |
| 8-K | 2026-09-10 | 2026-09-03 | CURRENT REPORT | 0001213900-26-098792 | View SEC Doc Filr Page |
| 8-K | 2026-09-02 | 2026-09-02 | CURRENT REPORT | 0001213900-26-096743 | View SEC Doc Filr Page |
| DEFA14A | 2026-08-19 | — | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-26-091729 | View SEC Doc Filr Page |
| 8-K | 2026-08-19 | 2026-08-18 | CURRENT REPORT | 0001213900-26-091438 | View SEC Doc Filr Page |
| 424B3 | 2026-08-17 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-090765 | View SEC Doc Filr Page |
| 424B3 | 2026-08-17 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-090758 | View SEC Doc Filr Page |
| 8-K | 2026-08-17 | 2026-08-17 | CURRENT REPORT | 0001213900-26-090746 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | QUARTERLY REPORT | 0001213900-26-090042 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-05 | CURRENT REPORT | 0001213900-26-085514 | View SEC Doc Filr Page |
| 8-K | 2026-07-22 | 2026-07-16 | CURRENT REPORT | 0001213900-26-080432 | View SEC Doc Filr Page |
| 8-K | 2026-07-01 | 2026-07-01 | CURRENT REPORT | 0001213900-26-074182 | View SEC Doc Filr Page |
| DEFA14A | 2026-06-23 | — | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-26-071173 | View SEC Doc Filr Page |
| DEF 14A | 2026-06-23 | 2026-08-18 | DEFINITIVE PROXY STATEMENT | 0001213900-26-071172 | View SEC Doc Filr Page |
| PRE 14A | 2026-06-01 | 2026-06-01 | PRELIMINARY PROXY STATEMENT | 0001213900-26-063543 | View SEC Doc Filr Page |
| 8-K | 2026-05-26 | 2026-05-19 | CURRENT REPORT | 0001213900-26-061039 | View SEC Doc Filr Page |
| 424B3 | 2026-05-21 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-060048 | View SEC Doc Filr Page |
| 424B3 | 2026-05-21 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-060045 | View SEC Doc Filr Page |
| 10-Q | 2026-05-20 | 2026-03-31 | QUARTERLY REPORT | 0001213900-26-059542 | View SEC Doc Filr Page |
| 8-K | 2026-05-20 | 2026-05-20 | CURRENT REPORT | 0001213900-26-059526 | View SEC Doc Filr Page |
| NT 10-Q | 2026-05-15 | 2026-03-31 | NOTIFICATION OF LATE FILING | 0001213900-26-057812 | View SEC Doc Filr Page |
| 424B3 | 2026-04-28 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-048270 | View SEC Doc Filr Page |
| 424B3 | 2026-04-28 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-048269 | View SEC Doc Filr Page |
| 8-K | 2026-04-28 | 2026-04-23 | CURRENT REPORT | 0001213900-26-048257 | View SEC Doc Filr Page |